Launch of range extension of neonatal ventilators

RNS Number : 9290T

Inspiration Healthcare Group PLC

23 March 2023

 

 23 March 2023

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Launch of range extension of specialist neonatal ventilators

Broadens the Company's reach into non-invasive ventilation

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces the launch of an extension to its range of neonatal ventilators. These are new variants of the SLE6000, Inspiration Healthcare's leading ventilator, that facilitates precise, controlled ventilation for critically ill infants. The products have been launched in the UK, where they will be sold directly and to selected international distributors. The roll out internationally will continue throughout the year.

The three new variants have been specifically designed to meet the specialist healthcare needs of some of the most vulnerable patients across critical care and high dependency care and all offer non-invasive respiratory support, which represents a new area of the market for the Company.

· The SLE6000H includes powerful high frequency oscillation, which actively controls pressure, volume and frequency to help protect the small and fragile lungs of critically ill patients;

· The SLE6000C includes full specification invasive and non-invasive modes, which can be easily adapted depenedent on the needs of the baby;

· The SLE6000N provides a suite of non-invasive, multi-mode respiratory support for less sick babies and those transitioning from respiratory support, enabling more important skin to skin contact between parents and baby.

Each variant also includes the option for Oxygenie®, the Company's automated oxygen control algorithm which is a key element in maintaining appropriate oxygen levels for neonates, helping to improve outcomes.

Neil Campbell, CEO of Inspiration Healthcare Group plc commented: "We're delighted to extend our range of ventilators with this launch, which is further demonstration of our continued commitment to pioneering innovative technologies to improve neonatal healthcare and help save the lives of premature babies around the world. We are excited about the potential of these products around the world."

For further information:

Inspiration Healthcare Group plc Neil Campbell, Chief Executive Officer		Tel: +44  (0)330 175 0000
Cenkos Securities plc (Nominated Adviser & Broker)		Tel: [phone]
Stephen Keys, Katy Birkin, Dan Hodkinson
Walbrook PR Ltd (Media and Investor Relations)	Tel: [phone]
Anna Dunphy/Stephanie Cuthbert

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.

Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products.  The Group generates approximately 58% of its revenues from export markets and more than half of its revenues come from its own-branded products.

With product availability actively promoted to over 80 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland, the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products.  This is supported by Technical Support for planned preventative maintenance and emergency assistance.

The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex).  The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport.

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com

 

END

 

 

NRAZZGZFLZNGFZM